An ultra-sensitive method to detect mutations in human RAS templates.

Journal Article (Journal Article)

The RAS family of small GTPases is mutated in roughly a fifth of human cancers. Hotspot point mutations at codons G12, G13, and Q61 account for 95% of all these mutations, which are well established to render the encoded proteins oncogenic. In humans, this family comprises three genes: HRAS, NRAS, and KRAS. Accumulating evidence argues that oncogenic RAS point mutations may be initiating, as they are often truncal in human tumours and capable of inducing tumorigenesis in mice. As such, there is great interest in detecting oncogenic mutation in the RAS genes to understand the origins of cancer, as well as for early detection purposes. To this end, we previously adapted the microbial ultra-sensitive Maximum Depth Sequencing (MDS) assay for the murine Kras gene, which was capable of detecting oncogenic mutations in the tissues of mice days after carcinogen exposure, essentially capturing the very first step in tumour initiation. Given this, we report here the adaption and details of this assay to detect mutations in a human KRAS sequence at an analytic sensitivity of one mutation in a million independently barcoded templates. This humanized version of MDS can thus be exploited to detect oncogenic mutations in KRAS at an incredible sensitivity and modified for the same purpose for the other RAS genes.

Full Text

Duke Authors

Cited Authors

  • Li, S; Counter, CM

Published Date

  • January 2022

Published In

Volume / Issue

  • 13 / 1

Start / End Page

  • 287 - 295

PubMed ID

  • 35658790

Pubmed Central ID

  • PMC9584555

Electronic International Standard Serial Number (EISSN)

  • 2154-1256

Digital Object Identifier (DOI)

  • 10.1080/21541248.2022.2083895


  • eng

Conference Location

  • United States